When was Provepharm Life Solutions founded?

Provepharm Life Solutions was founded in 1998 and raised its 1st funding round 13 years after it was founded.

Where is Provepharm Life Solutions located?

Provepharm Life Solutions is headquartered in Marseille, France.

Who is the current CEO of Provepharm Life Solutions?

Michel Feraud of Provepharm Life Solutions.

How many employees does Provepharm Life Solutions have?

As of Jun 30, 2026, the latest employee count at Provepharm Life Solutions is 120.

Is Provepharm Life Solutions a funded company?

Provepharm Life Solutions is a funded company, having raised a total of $146M across 4 funding rounds to date. The company's 1st funding round was a $***** PE round, raised on Dec 01, 2011.

When was the latest funding round of Provepharm Life Solutions?

Provepharm Life Solutions' latest funding was a $***** PE round on Sep 08, 2021, with participation from 6 investors.

Where does Provepharm Life Solutions rank among its competitors?

Provepharm Life Solutions ranks 27th amongst 959 active competitors, of which 37 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Enaltec Labs, which secured $1.33M in Jan, 2022.

Who are the top competitors of Provepharm Life Solutions?

Provepharm Life Solutions' top competitors include Laurus Labs, Symbiotec and NGL Fine Chem. Among them, Enaltec Labs secured the most recent funding round in January, 2022.

Provepharm Life Solutions - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provepharm is a specialty pharma company, offering specialty products, preclinical services, API production & FDF for the clinical trial. The company products include methylene blue compound, methylthioninium chloride solution, methylene blue solution for injection, and methylrnr blue sterile solution.

Website: www.provepharm.com/
Social
Phone Number: +33 **********

Key Metrics

Founded Year

1998

Location

Marseille, France

Stage

Late Stage

Total Funding

$146M in 4 rounds

Latest Funding Round

PE, Sep 08, 2021, $*****

Investors

Societe Generale & 10 more

Ranked

27^th among 959 active competitors

Employee Count

120 as on Jun 30, 2026

Investment & Acquisitions

Apollo Pharmaceuticals

Similar Companies

Laurus Labs & 1223 more

View Provepharm Life Solutions' full profile

Provepharm Life Solutions has raised a total funding of $146M over 4 rounds. Its first funding round was on Dec 01, 2011. Its latest funding round was a PE round on Sep 08, 2021 for $*****. 6 investors participated in its latest round. Provepharm Life Solutions has 11 institutional investors.

Here is the list of recent funding rounds of Provepharm Life Solutions:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 08, 2021	2381191	PE	2313347	5823658	8272010	4500759
May 09, 2019	2518377	Conventional Debt	3522500	1778452	7950897	Societe Generale & 3 more
Mar 23, 2018	4447970	PE	8409482	6585181	5297005	Tethys Investments & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Provepharm Life Solutions's funding rounds and investors

Provepharm Life Solutions' employee count trend

Provepharm Life Solutions has 120 employees as of Jun 26. Here is Provepharm Life Solutions's employee count trend over the years:

Employee count trend for Provepharm Life Solutions

Uncover Provepharm Life Solutions' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Provepharm Life Solutions include Laurus Labs, Symbiotec and NGL Fine Chem. Here is the list of Top 10 competitors of Provepharm Life Solutions, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Laurus Labs 2005, Hyderabad (India), Public	Pharmaceutical and biotechnology company	$230M	IKP Knowledge Park, Eight Roads Ventures & 3 others	70/100
2nd	Symbiotec 2002, Indore (India), Acquired	Manufacturer of non sterile steroid hormone based APIs and intermediates	$61.1M	Franklin Templeton Investments, Actis & 21 others	63/100
3rd	NGL Fine Chem 1981, Mumbai (India), Public	CDMO specializing in multi stage organic synthesis of generic APIs and fine chemicals	-	-	59/100
4th	Neuland 1984, Hyderabad (India), Public	Manufacturer of active pharmaceutical ingredients (APIs) and peptides	-	InvAscent, India Capital Growth & 1 others	58/100
5th	Embio 1986, Mumbai (India), Early Stage	Contract research and manufacturing company engaged in APIs and chiral intermediates	$292K	UTI, GURU NARAYAN FINCAP & 25 others	57/100
6th	Hikal 1988, Mumbai (India), Public	Traditional company offering contract research, custom synthesis & custom manufacturing of APIs and intermediates	-	IFC	57/100
7th	IDT Australia Limited 1975, Boronia (Australia), Public	Providing cannabis product development and manufacturing services from API	$6M	CVC, I'Rom Group	54/100
8th	ST PHARM 2008, Siheung si (South Korea), Public	CDMO providing oligonucleotide, mRNA, and small molecule services	-	E&Investment, Shinhan Venture Investment & 1 others	53/100
9th	SMS LifeSciences 2006, Hyderabad (India), Public	Manufacturer of Active Pharmaceutical Ingredients (API) and intermediate	-	-	53/100
10th	Enaltec Labs 2006, Mumbai (India), Acquired	Provider of complex small-volume technology-driven pharmaceutical products	$8.56M	InvAscent, Medtech Global & 7 others	52/100
27th	Provepharm Life Solutions 1998, Marseille (France), Late Stage	Pharmaceutical company dedicated towards the development and valorization of APIs and drug Products	$146M	BNP Paribas, Societe Generale & 9 others	45/100